Dr. Clifford Jack, MD

• Radiology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Mayo Clinic-rochester

  Fellowship Hospital

• Henry Ford Hospital

  Internship Hospital

• The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable, 2018-12-21

• Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects, 2011-04-08

• Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge, 2015-12-01

• The influence of tau, amyloid, alpha-synuclein, TDP-43 and vascular pathology in clinically normal elderly individuals, 2019-01-21

• Relationship Between Risk Factors and Brain Reserve in Late Middle Age: Implications for Cognitive Aging, 2020-01-09

• Davunetide for Progressive Supranuclear Palsy: a multicenter, randomized, double-blind, placebo controlled trial, 2014-05-27

• Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study, 2023-03-19

• Performance of the CogState computerized battery in the Mayo Clinic Study on Aging, 2015-04-06

• Cardiovascular risk factors, cortisol, and amyloid-ß deposition in Alzheimer's Disease Neuroimaging Initiative, 2013-04-30

• Regional white matter hyperintensities in posterior cortical atrophy and logopenic progressive aphasia, 2022-07-28

• MAPThaplotype H1G is associated with increased risk of dementia with Lewy bodies, 2016-06-07

• Neuroimaging correlates of pathologically-defined atypical Alzheimer's disease, 2012-09-03

• Association of white matter microstructural integrity with cognition and dementia, 2019-08-29

• Multimodal neuroimaging relationships in progressive supranuclear palsy, 2019-07-02

• Reduced fractional anisotropy of genu of corpus callosum as a predictor of longitudinal cognition in MCI, 2020-09-08

• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, 2011-04-21

• Regional ß-amyloid burden does not correlate with cognitive or language deficits in Alzheimer's disease presenting as aphasia, 2015-06-23

• Mediterranean diet, micro- and macronutrients, and MRI measures of cortical thickness, 2016-07-25

• MRS in Early and Presymptomatic Carriers of a Novel Octapeptide Repeat Insertion in the Prion Protein Gene, 2012-05-21

• Diffusion tensor imaging analysis in three progressive supranuclear palsy variants, 2021-03-12

• Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials, 2017-03-22

• A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech, 2021-06-08

• Life-course blood pressure in relation to brain volumes, 2016-04-29

• Cerebral Amyloid Angiopathy Burden and Cerebral Microbleeds: Pathological Evidence for Distinct Phenotypes, 2021-04-28

• 1H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults, 2022-01-05

• Tau-PET imaging with [18F]AV-1451 in Primary Progressive Apraxia of Speech, 2018-01-02

• Predicting survival in Dementia with Lewy Bodies with hippocampal volumetry, 2016-05-23

• Blood Pressure and White Matter Disease Progression in a Biethnic Cohort: The Atherosclerosis Risk in Communities (ARIC) Study, 2009-11-19

• On the path to 2025: understanding the Alzheimer's disease continuum, 2017-08-09

• Comparison of [18F]Flutemetamol and [11C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals, 2017-08-14

• [18F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease, 2018-02-06

• Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for Clinical Trials in Alzheimer's disease, 2015-03-20

• The neuroanatomic correlates of olfactory identification impairment in healthy older adults and in persons with mild cognitive impairment, 2023-03-20

• Population-Based Prevalence of Infarctions on 3D Fluid-Attenuated Inversion Recovery (FLAIR) Imaging Infarction prevalence on 3D FLAIR, 2022-06-08

• Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN), 2023-07-10

• Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort, 2015-11-19

• Imaging correlations of tau, amyloid, metabolism and atrophy in typical & atypical AD, 2018-03-30

• The Impact of Amyloid Burden andAPOEon Rates of Cognitive Impairment in Late Life Depression, 2022-02-16

• Comparison of variables associated with CSF neurofilament, total-tau, and neurogranin, 2019-10-23

• Diagnostic accuracy of the Cogstate Brief Battery for prevalent MCI and prodromal AD (MCI A+T+) in a population-based sample, 2021-03-01

• Cerebrospinal Fluid Dynamics and Discordant Amyloid Biomarkers, 2021-11-01

• Common variants at 6q22 and 17q21 are associated with intracranial volume, 2012-04-15

• Algebraic connectivity of brain networks shows patterns of segregation leading to reduced network robustness in Alzheimer's disease, 2014-12-12

• Elevated Plasma Ceramides are Associated with Higher White Matter Hyperintensity Volume-Brief Report, 2019-09-12

• AV-1451 Tau andß-Amyloid Positron Emission Tomography Imaging in Dementia With Lewy Bodies, 2016-12-19

• Effects of hardware heterogeneity on the performance of SVM Alzheimer's disease classifier, 2011-06-25

• Regional Proton Magnetic Resonance Spectroscopy Patterns in Dementia with Lewy Bodies, 2014-01-08

• Excessive daytime sleepiness and fatigue may indicate accelerated brain aging in cognitively normal late middle-aged and older adults, 2016-11-03

• Sleep quality and cortical amyloid-ß deposition in postmenopausal women of the Kronos Early Estrogen Prevention Study (KEEPS), 2021-03-03

• Very Early Semantic Dementia With Progressive Left»Right Temporal Lobe Atrophy: An Eight-Year Longitudinal Study, 2010-05-06

• Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder, 2011-11-22

• Mapping Dynamic Changes in Ventricular Volume onto Baseline Cortical Surfaces in Normal Aging, MCI, and Alzheimer's Disease, 2014-05-03

• Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials, 2011-11-13

• Effects of changing from non-accelerated to accelerated MRI for follow-up in brain atrophy measurement, 2014-12-04

• The Prospective Association between Periodontal Disease and Brain Imaging Outcomes: The Atherosclerosis Risk in Communities Study, 2022-01-27

• Frequency and Topography of Cerebral Microbleeds in Dementia with Lewy bodies Compared to Alzheimer's Disease, 2015-07-14

• VENTRICULAR MAPS IN 804 SUBJECTS CORRELATE WITH COGNITIVE DECLINE, CSF PATHOLOGY, AND IMMINENT ALZHEIMER'S DISEASE, 2010-06-21

• Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N=1198) using genome-wide search, 2011-04-19

• Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities, 2021-09-27

• MRI quantitative susceptibility mapping of the substantia nigra as an early biomarker for Lewy body disease, 2021-05-25

• The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception, 2013-08-07

• [18F]AV-1451 tau-PET in progressive supranuclear palsy, 2016-10-27

• Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC), 2016-07-14

• Presymptomatic atrophy in autosomal dominant Alzheimer's disease: a serial MRI study, 2017-07-22

• Functional Connectivity in Autosomal Dominant and Late-Onset Alzheimer Disease, 2014-10-25

• Prosodic and Phonetic Subtypes of Primary Progressive Apraxia of Speech, 2018-07-04

• Association of Longitudinal ß-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia ß-Amyloid Accumulation and Decline in Adults With Probable Lewy Body Dementia, 2019-12-02

• Anatomical Differences between CBS-Corticobasal degeneration and CBS-Alzheimer's Disease, 2010-07-15

• A standard system phantom for magnetic resonance imaging, 2021-04-13

• Sex and age differences in atrophic rates: an ADNI study with N=1368 MRI scans, 2010-07-19

• APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia: Implications for therapeutic strategy, 2021-09-29

• MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration, 2009-03-19

• Increasing participant diversity in AD research: plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4, 2022-10-09

• Mapping ventricular expansion onto cortical gray matter in older adults, 2014-08-30

• CORTICAL THICKNESS AND DEPRESSIVE SYMPTOMS IN COGNITIVELY NORMAL INDIVIDUALS: THE MAYO CLINIC STUDY OF AGING, 2017-11-30

• An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease, 2016-08-10

• White Matter Integrity on DTI and the Pathologic Staging of Alzheimer's Disease, 2017-05-04

• Factors affecting Aß plasma levels and their utility as biomarkers in ADNI, 2011-07-30

• Selective Worsening of Brain Injury Biomarker Abnormalities in Cognitively Normal Elderly with ß-amyloidosis, 2013-12-25

• Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study on 198 serial MRI, 2015-02-12

• Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014, 2015-11-17

• Role of ß-amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment, 2015-12-01

• LRRK2variation and dementia with Lewy bodies, 2016-07-29

• Regional Brain Stiffness Analysis of Dementia with Lewy Bodies, 2021-10-23

• Left-Right Intensity Asymmetries Vary Depending on Scanner Model for FLAIR and T1Weighted MRI Images, 2022-02-08

• MRS in Mild Cognitive Impairment: Early Differentiation of Dementia with Lewy Bodies and Alzheimer's Disease, 2014-07-15

• Frontal asymmetry in behavioral variant FTD: clinicoimaging & pathogenetic correlates, 2012-04-11

• A face-off of MRI research sequences by their need for de-facing, 2023-06-01

• Cerebral amyloid PET imaging in Alzheimer's disease, 2013-10-08

• Varying degrees of temporoparietal hypometabolism on FDG-PET reveal amyloid-positive logopenic primary progressive aphasia is not a homogeneous clinical entity, 2018-03-21

• The Effect of Subsyndromal Symptoms of Depression and White Matter Lesions on Disability for Individuals with Mild Cognitive Impairment, 2013-02-06

• White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline, 2021-04-12

• Ventricular atrophy and its clinical correlates in the imaging cohort from the ADCS MCI Donepezil/Vitamin E study, 2012-08-01

• White matter integrity in dementia with Lewy bodies: A Voxel-Based Analysis of Diffusion Tensor Imaging, 2015-03-14

• Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures, 2022-07-14

• Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease, 2021-09-28

• Age, Vascular Health, and Alzheimer's disease Biomarkers in an Elderly Sample, 2017-10-26

• Obesity is linked with lower brain volume in 700 AD and MCI patients, 2010-06-08

• Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: An ADNI study of 515 subjects, 2009-07-14

• Symmetric corticobasal degeneration (S-CBD), 2009-12-16

• APOEeffect on Alzheimer's biomarkers in older adults with significant memory concern, 2015-05-07

• Unbiased tensor-based morphometry: Improved robustness and sample size estimates for Alzheimer's disease clinical trials, 2012-11-12

• Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging, 2014-11-15

• The Association of Motoric Cognitive Risk with Incident Dementia and Neuroimaging Characteristics: The Atherosclerosis Risk in Communities Study, 2021-11-17

• Brain Imaging Features Associated with 20-Year Cognitive Decline in a Community-Based Multiethnic Cohort Without Dementia, 2022-05-02

• Automatic quality assessment in structural brain magnetic resonance imaging, 2009-10-09

• The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data, 2014-01-08

• Regional distribution, asymmetry and clinical correlates of tau uptake on [18F]AV-1451 PET in atypical Alzheimer's disease, 2018-09-01

• Detection of ß-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers, 2021-02-02

• TDP-43 is a key player in the clinical features associated with Alzheimer's disease, 2014-03-23

• Relationship ofAPOE, age at onset, amyloid and clinical phenotype in Alzheimer disease, 2021-08-25

• Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds, 2022-09-02

• Cerebral microbleeds, CSF p-tau, and cognitive decline: significance of anatomical distribution, 2015-07-30

• Sample size calculations for clinical trials targeting tauopathies: A new potential disease target, 2015-06-17

• Influence of Preeclampsia and Late-Life Hypertension on MRI Measures of Cortical Atrophy, 2017-07-25

• The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI), 2013-04-01

• Non-right handed primary progressive apraxia of speech, 2018-05-07

• Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech, 2015-05-27

• Association of functional performance with Alzheimer's disease biomarkers in non-demented individuals, 2018-11-21

• Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains, 2019-01-02

• Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly, 2013-01-23

• A single nucleotide polymorphism associated with reduced alcohol intake in theRASGRF2gene predicts larger cortical volumes but faster longitudinal ventricular expansion in the elderly, 2013-12-19

• Location of pathogenic variants inPSEN1impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease, 2023-06-08

• Comparing 3 T and 1.5 T MRI for Tracking Alzheimer's Disease Progression with Tensor-Based Morphometry, 2009-08-06

• 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception, 2016-11-17

• Effect of APOE e4 Status on Intrinsic Network Connectivity in Cognitively Normal Elderly, 2011-05-09

• Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers, 2021-03-04

• Cross-scanner harmonization methods for structural MRI may need further work: A comparison study, 2023-01-31

• Optimum differentiation of FTLD from AD achieved with cross-sectional tau PET, 2022-08-29

• Testing the Right Target and the Right Drug at the Right Stage, 2011-11-30

• Estimating long-term multivariate progression from short-term data, 2014-03-20

• Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer's disease: a series of clinical cases, 2022-02-25

• The Metabolic Syndrome and Cognitive Decline in the Atherosclerosis Risk in Communities Study (ARIC), 2014-08-20

• Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type, 2017-05-16

• Massachusetts alzheimer's disease research center: Progress and challenges, 2015-08-19

• Alzheimer's Disease Neuroimaging Initiative: A one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition, 2009-04-15

• Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration, 2022-08-30

• Elevated occipital ß-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia, 2013-08-14

• Accurate Measurement of Brain Changes in Longitudinal MRI Scans using Tensor-Based Morphometry, 2011-02-23

• NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease, 2018-04-24

• Cerebral Microbleeds: Relationship to Antithrombotic Medications, 2021-05-10

• CSF Phosphorylated Tau as an Indicator of Subsequent Tau Accumulation, 2022-05-26

• Mediterranean diet, its components and amyloid imaging biomarkers, 2018-06-28

• Association of mid-life serum lipid levels with late-life brain volumes: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS), 2020-09-01

• White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition, 2022-02-05

• Neuroimaging Correlates with Neuropathologic Schemes in Neurodegenerative Disease, 2019-06-04

• Time-to-event Voxel Based Techniques to Assess Regional Atrophy Associated with MCI Risk of Progression to AD, 2010-09-09

• Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau-PET and amyloid-PET, 2018-04-05

• Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration Association of Bilateral Salpingo-Oophorectomy Before Menopause With Medial Temporal Lobe Neurodegeneration, 2018-10-15

• Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels, 2022-12-27

• MRI outperforms [18F]AV-1451 PET as a longitudinal biomarker in progressive supranuclear palsy, 2018-11-23

• Amyloid Burden Correlates with Cognitive Decline in Alzheimer's Disease Presenting with Aphasia, 2013-12-16

• Sensitivity-specificity of tau and Aß PET in frontotemporal lobar degeneration, 2020-09-12

• 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons, 2014-03-11

• Functional Impact of White Matter Hyperintensities in Cognitively Normal Elderly, 2010-12-06

• Novel genetic loci underlying human intracranial volume identified through genome-wide association, 2016-10-03

• TDP-43 in Alzheimer's disease is not associated with clinical FTLD or Parkinsonism, 2014-04-24

• Effects of traumatic brain injury and posttraumatic stress disorder on development of Alzheimer's disease in Vietnam Veterans using the Alzheimer's Disease Neuroimaging Initiative: Preliminary Report, 2017-04-21

• Aortic hemodynamics and white matter hyperintensities in normotensive postmenopausal women, 2017-04-07

• Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease, 2019-04-10

• Caudate atrophy on MRI is a characteristic feature of FTLD-FUS, 2010-03-03

• Predicting Clinical Scores from Magnetic Resonance Scans in Alzheimer's Disease, 2010-03-25

• The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception, 2011-11-02

• Trajectory of Lobar Atrophy in Asymptomatic and SymptomaticGRNMutation Carriers: a Longitudinal MRI Study, 2019-12-12

• The association of mid- and late-life systemic inflammation with brain amyloid deposition: The ARIC-PET Study, 2018-09-21

• 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects, 2010-06-11

• Clinical and Neuroimaging Characteristics of Clinically Unclassifiable Primary Progressive Aphasia, 2019-08-13

• Effects of age on the glucose metabolic changes in mild cognitive impairment, 2010-03-18

• Comparison of18F-FDG and PiB PET in Cognitive Impairment, 2009-05-14

• Tau, Amyloid, and Cascading Network Failure across the Alzheimer's disease Spectrum, 2017-10-03

• Performance of plasma phosphorylated tau 181 and 217 in the community, 2022-05-26

• Non-Stationarity in the "Resting Brain's” Modular Architecture, 2012-06-28

• Deep learning-based brain age prediction in normal aging and dementia, 2022-05-09

• FDG PET and MRI in Logopenic Primary Progressive Aphasia versus Dementia of the Alzheimer's Type, 2013-04-23

• NIA-AA Alzheimer's Disease Framework: Clinical Characterization of Stages, 2021-03-26

• Clinical correlates of white matter tract degeneration in PSP, 2012-07-02

• Factors Associated with Meningioma Detected in a Population-Based Sample, 2019-05-08

• Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline, 2021-07-26

• White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease, 2018-09-25

• Longitudinal Tau PET in Dementia with Lewy Bodies, 2022-03-08

• Standardization of Analysis Sets for Reporting Results from ADNI MRI Data, 2012-10-27

• The role of age on tau PET uptake and grey matter atrophy in atypical Alzheimer disease, 2019-03-08

• Ecology of aging human brain, 2011-11-01

• 18F-AV-1451 uptake differs between dementia with Lewy bodies and posterior cortical atrophy, 2019-01-07

• Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging, 2022-02-09

• Protective Variant for Hippocampal Atrophy Identified by Whole Exome Sequencing, 2015-02-14

• Microbleeds in the logopenic variant of primary progressive aphasia, 2013-04-03

• Cortical ß-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging, 2019-03-28

• Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk, 2022-02-02

• Tau Uptake in Agrammatic Primary Progressive Aphasia with and without Apraxia of Speech, 2018-07-26

• Neuroimaging correlates of cerebral microbleeds: The Atherosclerosis Risk in Communities (ARIC) study, 2017-10-10

• Patterns of Brain Atrophy in Clinical Variants of Frontotemporal Lobar Degeneration, 2013-01-09

• Rich club analysis in the Alzheimer's disease connectome reveals a relatively undisturbed structural core network, 2015-06-03

• Update on the MRI Core of the Alzheimer's Disease Neuroimaging Initiative, 2010-05-03

• Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, 2014-12-24

• Changing the face of neuroimaging research: Comparing a new MRI de-facing technique with popular alternatives, 2021-02-11

• Grey and white matter correlates of dysphagia in progressive supranuclear palsy, 2021-08-23

• Sex difference in the relation between marital status and dementia risk in two population-based cohorts, 2021-09-04

• A comparison of cross-sectional and longitudinal methods of defining objective subtle cognitive decline in preclinical Alzheimer's disease based on Cogstate One Card Learning accuracy performance, 2021-09-22

• Pittsburgh Compound B and AV-1451 Positron Emission Tomography Assessment of Molecular Pathologies of Alzheimer's disease in Progressive Supranuclear Palsy, 2017-12-13

• Association of Apolipoprotein E ?4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults Association ofAPOE?4, Education, and Sex With Tau Pathology in Older Adults, 2019-10-23

• Association of Carotid Intima-Media Thickness with Brain MRI Markers in the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS), 2022-02-19

• Association of Lifetime Intellectual Enrichment with Cognitive Decline in the Older Population, 2014-12-05

• BRAIN MRI AFTER CRITICAL CARE ADMISSION: A LONGITUDINAL IMAGING STUDY, 2020-12-05

• White Matter Integrity on DTI, Amyloid Load, and Neurodegeneration in Non-demented Elderly, 2016-03-15

• Cerebral Amyloid Deposition is Associated with Gait Parameters in the Mayo Clinic Study of Aging, 2016-11-21

• Identification of an atypical variant of logopenic progressive aphasia, 2013-04-06

• Brain Injury Biomarkers Are Not Dependent on ß-amyloid in Normal Elderly, 2013-02-19

• A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease, 2021-06-21

• Obesity, insulin resistance and incident small vessel disease on MRI: the Atherosclerosis Risk in Communities Study, 2015-10-08

• Common genetic variants influence human subcortical brain structures, 2015-01-21

• The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology, 2021-05-21

• Deep learning identifies brain structures that predict cognition and explain heterogeneity in cognitive aging, 2022-02-20

• Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia, 2008-09-25

• Predicting Progression to Mild Cognitive Impairment, 2019-01-07

• Modeling autosomal dominant Alzheimer's disease with machine learning, 2021-01-21

• Measuring the effects of aging and sex on regional brain stiffness with MR elastography in healthy older adults, 2015-02-17

• Angular versus spatial resolution trade-offs for diffusion imaging under time constraints, 2012-04-21

• The transitional association between ß-amyloid pathology and regional brain atrophy, 2014-12-09

• Histologic lesion type correlates of magnetic resonance imaging biomarkers in four-repeat tauopathies, 2022-04-28

• Prevalence and Natural History of Superficial Siderosis: A Population-based Study, 2017-10-25

• Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?, 2013-01-24

• Interpreting scan data acquired from multiple scanners: A study with Alzheimer's disease, 2008-02-01

• DEPRESSIVE AND ANXIETY SYMPTOMS AND CORTICAL AMYLOID DEPOSITION AMONG COGNITIVELY NORMAL ELDERLY PERSONS: THE MAYO CLINIC STUDY OF AGING, 2017-12-04

• Drug development in Alzheimer's disease: the path to 2025, 2016-09-20

• Progressive dysexecutive syndrome due to Alzheimer's disease: a description of 55 cases and comparison to other phenotypes, 2020-05-27

• Longitudinal beta-amyloid PET in atypical Alzheimer's disease and frontotemporal lobar degeneration, 2020-03-04

• Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline, 2022-11-10

• Imaging Biomarkers of Alzheimer's Disease in Multiple Sclerosis, 2020-02-08

• Focal Hemosiderin Deposits and ß-Amyloid Load in the ADNI Cohort, 2013-01-30

• Vascular imaging abnormalities and cognition: Mediation by Cortical Volume in non-demented persons: ARIC-NCS Study, 2015-01-06

• Progranulin-associated PiB-negative logopenic primary progressive aphasia, 2014-01-22

• An MRI-based atlas for correlation of imaging and pathologic findings in Alzheimer's disease, 2016-03-28

• Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry, 2017-10-27

• Neuronal insulin signaling and brain structure in non-demented older adults: The ARIC Study, 2020-10-01

• 3-D Tract-Specific Local and Global Analysis of White Matter Integrity in Alzheimer's Disease, 2016-11-24

• Discovery and Replication of Gene Influences on Brain Structure Using LASSO Regression, 2012-08-06

• Tracking the Development of Agrammatic Aphasia: a Tensor-Based Morphometry Study, 2016-09-30

• Joint associations of ß-amyloidosis and cortical thickness with cognition, 2018-02-02

• Biomarker Modeling of Alzheimer's Disease, 2013-12-18

• APOE4 influences ß-amyloid burden in primary progressive aphasia and speech apraxia, 2014-06-28

• Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities, 2019-07-15

• Neuroimaging Biomarkers and Impaired Olfaction in Cognitively Normal Individuals, 2017-06-09

• Working memory and language network dysfunction in logopenic aphasia: a task-free fMRI comparison to Alzheimer's dementia, 2014-12-16

• Primary Lateral Sclerosis as Progressive Supranuclear Palsy: Diagnosis by Diffusion Tensor Imaging, 2012-04-19

• Functional connectivity to the premotor cortex maps onto longitudinal brain neurodegeneration in progressive apraxia of speech, 2022-09-02

• Longitudinal flortaucipir ([18F]AV-1451) PET uptake in Semantic Dementia, 2020-04-18

• Quantitative neurofibrillary tangle density and brain volumetric MRI analyses in Alzheimer's disease presenting as logopenic progressive aphasia, 2013-03-28

• Imaging signatures of molecular pathology in behavioral variant frontotemporal dementia, 2011-05-10

• Tracking white matter degeneration in asymptomatic and symptomaticMAPTmutation carriers, 2019-08-15

• Statins and Brain Health: Alzheimer's and Cerebrovascular Disease Biomarkers in Older Adults, 2018-11-07

• Longitudinal deterioration of white-matter integrity: heterogeneity in the ageing population, 2021-01-22

• A Quantitative Postmortem MRI Design Sensitive to White Matter Hyperintensity Differences and their Relationship with Underlying Pathology, 2012-11-14

• [18F]AV-1451 tau-PET and primary progressive aphasia, 2018-03-13

• PART, a distinct tauopathy, different from classical sporadic Alzheimer disease, 2015-03-17

• DETECTION OF ALZHEIMER'S DISEASE USING ELECSYS AMYLOID-BETA 1-42, P-TAU AND T-TAU assays, 2021-07-26

• Boosting power for clinical trials using classifiers based on multiple biomarkers, 2010-06-11

• Association between brain health outcomes and metabolic risk factors in persons with diabetes E. L. Reynoldset al., 2023-07-30

• Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort, 2010-01-25

• Longitudinal Flortaucipir ([18F]AV-1451) PET Imaging in Primary Progressive Apraxia of Speech, 2019-11-19

• Midlife systemic inflammation, late-life white matter integrity, and cerebral small vessel disease: The ARIC Study, 2017-11-03

• Pattern of Brain Atrophy Rates in Autopsy-Confirmed Dementia with Lewy Bodies, 2014-07-15

• Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease, 2021-05-13

• Empowering Imaging Biomarkers of Alzheimer's Disease, 2014-08-27

• 18F-AV-1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy Nedelska et al, 2019-01-07

• Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes, 2021-12-14

• PREDICTING TEMPORAL LOBE VOLUME ON MRI FROM GENOTYPES USING L1-L2REGULARIZED REGRESSION, 2012-07-17

• Regional multimodal relationships between tau, hypometabolism, atrophy and fractional anisotropy in atypical Alzheimer's disease, 2018-12-13

• The Alzheimer's Disease Neuroimaging Initiative 3: continued innovation for clinical trial improvement, 2016-12-05

• Common folate gene variant,MTHFRC677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment, 2012-10-04

• Posterior cortical atrophy phenotypic heterogeneity revealed by decoding18F-FDG-PET, 2021-08-19

• Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: A clinico-imaging-pathological study of primary age related tauopathy (PART), 2017-02-03

• Diffusion MRI Indices and Their Relation to Cognitive Impairment in Brain Aging: The Updated Multi-protocol Approach in ADNI3, 2019-02-19

• Maximizing power to track Alzheimer's disease and MCI progression by LDA-based weighting of longitudinal ventricular surface features, 2013-01-04

• Imaging-based indices of Neuropathology and gait speed decline in older adults: the atherosclerosis risk in communities study, 2021-01-13

• Common variants at 12q14 and 12q24 are associated with hippocampal volume, 2012-04-15

• Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa, 2019-05-02

• Nonlinear time course of brain volume loss in cognitively normal and impaired elders, 2010-09-19

• Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration, 2022-02-07

• Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia, 2015-02-03

• Effects of Baseline CSF a-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer's Disease, 2013-12-31

• Plasma biomarkers for prediction of Alzheimer's disease neuropathologic change, 2023-06-03

• CHRONIC DEPRESSIVE SYMPTOMATOLOGY IN MILD COGNITIVE IMPAIRMENT IS ASSOCIATED WITH FRONTAL ATROPHY RATE WHICH HASTENS CONVERSION TO ALZHEIMER DEMENTIA, 2015-03-30

• Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity, 2022-07-11

• Rates of hippocampal atrophy and post-mortem TDP-43 in Alzheimer's disease: a longitudinal retrospective study, 2017-09-11

• Antemortem amyloid imaging and ß-amyloid pathology in a case with dementia with Lewy Bodies, 2010-10-18

• Common genetic variation indicates separate etiologies for periventricular and deep white matter hyperintensities, 2020-06-10

• Posterior Cortical Atrophy: Primary Occipital Variant, 2022-03-30

• Alzheimer's Disease Disrupts Rich Club Organization in Brain Connectivity Networks, 2014-05-03

• Diabetes and Elevated HbA1c levels are Associated with Brain Hypometabolism but not Amyloid Accumulation, 2014-03-20

• [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy confirmed corticobasal degeneration, 2016-09-19

• Staging TDP-43 pathology in Alzheimer's disease, 2013-11-16

• Prevalence and Heterogeneity of Cerebrovascular Disease Imaging Lesions, 2020-05-06

• Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criteria for Alzheimer's disease, 2012-07-02

• Evolution of Neurodegeneration Imaging Biomarkers from Clinically Normal to Dementia in the Alzheimer Disease Spectrum, 2016-06-16

• Homocysteine effects on brain volumes mapped in 732 elderly individuals, 2011-06-11

• Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population based elderly cohort, 2016-07-18

• Defining imaging biomarker cut-points for brain aging and Alzheimer's disease, 2016-09-30

• Functional MRI Changes in Amnestic and Non-Amnestic MCI During Encoding and Recognition Tasks, 2009-07-09

• Early Postmenopausal Transdermal 17ß-Estradiol Therapy and Amyloid-ß Deposition, 2016-05-07

• The clinical use of structural MRI in Alzheimer disease, 2010-08-25

• The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans, 2010-07-01

• Antemortem Differential Diagnosis of Dementia Pathology using Structural MRI: Differential-STAND, 2010-12-31

• Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies, 2021-05-14

• An autoradiographic evaluation of AV-1451 Tau PET in dementia, 2016-06-13

• Voxel-based morphometry in patients with obsessive-compulsive behaviors in behavioral variant frontotemporal dementia, 2012-01-28

• Neurocognition in Individuals with Incidentally-Identified Meningioma, 2017-05-25

• Depressive Symptoms in Mild Cognitive Impairment Predict Greater Atrophy in Alzheimer's Disease-Related Regions, 2012-02-08

• Phonological errors in posterior cortical atrophy, 2021-07-16

• Effects of CSF proteins on brain atrophy rates in cognitively healthy older adults, 2013-10-01

• FEATURE SELECTION IMPROVES THE ACCURACY OF CLASSIFYING ALZHEIMER DISEASE USING DIFFUSION TENSOR IMAGES, 2015-03-31

• Diagnostic neuroimaging across diseases, 2011-11-07

• The added value of diffusion-weighted MRI-derived structural connectome in evaluating mild cognitive impairment: a multi-cohort validation, 2018-11-21

• Association of Kidney Function Biomarkers with Brain MRI Findings: The BRINK Study, 2017-09-06

• Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum, 2021-10-14

• Atrial Fibrillation, Brain Volumes, and Subclinical Cerebrovascular Disease (from the Atherosclerosis Risk in Communities Neurocognitive Study [ARIC-NCS]), 2019-10-26

• CSF dynamics as a predictor of cognitive progression, 2021-02-23

• Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment Association of MRI Signs With Cognitive Outcomes in Nonimpaired Cognition and Mild Cognitive Impairment, 2019-05-10

• Midbrain atrophy is not a biomarker of PSP pathology, 2013-06-07

• Evidence against a temporal association between cerebrovascular disease and Alzheimer's disease imaging biomarkers, 2023-05-29

• SPECTRAL GRAPH THEORY AND GRAPH ENERGY METRICS SHOW EVIDENCE FOR THE ALZHEIMER'S DISEASE DISCONNECTION SYNDROME INAPOE-4 RISK GENE CARRIERS, 2015-03-28

• Uptake of AV-1451 in meningiomas, 2017-09-08

• Age and sex specific prevalences of cerebral ß-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study, 2017-04-26

• Mapping Alzheimer's disease progression in 1309 MRI scans: Power estimates for different inter-scan intervals?, 2010-02-06

• The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function, 2015-12-29

• FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD, 2021-07-04

• Genome-wide association identifies genetic variants associated with lentiform nucleus volume inN=1345 young and elderly subjects, 2013-06-21

• Tau-PET Correlates with Neuropathology Findings, 2020-01-04

• Ventricular Maps in 804 Adni Subjects: Correlations with CSF Biomarkers & Clinical Decline, 2010-06-04

• Association of amyloid angiopathy with microbleeds in logopenic progressive aphasia: an imaging-pathology study, 2020-11-12

• 18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus, 2018-02-28

• Face recognition from research brain PET: An unexpected PET problem, 2022-06-03

• Update on hypothetical model of Alzheimer's disease biomarkers, 2013-01-31

• Magnetic Resonance Imaging in ADNI, 2015-07-21

• Cardiometabolic health and longitudinal progression of white matter hyperintensity: The Mayo Clinic Study of Aging, 2019-09-12

• The genetic architecture of the human cerebral cortex, 2020-03-20

• Study of Symptomatic vs. Silent Brain Infarctions on MRI in Elderly Subjects, 2021-02-17

• Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy, 2016-04-24

• Automatic classification of MR scans in Alzheimer's disease, 2008-01-17

• Neuroimaging comparison of Primary Progressive Apraxia of Speech & Progressive Supranuclear Palsy, 2012-10-18

• Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging, 2021-04-24

• Predictive value of ATN biomarker profiles in estimating disease progression in Alzheimer's disease dementia, 2021-11-10

• Association of Cortical and Subcortical ß-Amyloid With Standardized Measures of Depressive and Anxiety Symptoms in Adults Without Dementia, 2020-10-22

• Diagnostic and prognostic accuracy of the Cogstate Brief Battery and Auditory Verbal Learning Test in preclinical Alzheimer's disease and incident Mild Cognitive Impairment: implications for defining subtle objective cognitive impairment, 2020-09-24

• Associations between cerebrospinal fluids total phosphatidylcholines, neurodegeneration, cognitive decline and risk of mild cognitive impairment in the Mayo Clinic Study of Aging, 2020-04-28

• Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors, 2017-11-08

• Genetic architecture of subcortical brain structures in 38,851 individuals, 2019-10-21

• Focal brain atrophy in gastric bypass patients with cognitive complaints, 2011-11-15

• HOW DO SPATIAL AND ANGULAR RESOLUTION AFFECT BRAIN CONNECTIVITY MAPS FROM DIFFUSION MRI?, 2012-07-17

• Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: an MRI and FDG-PET study, 2013-03-28

• White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease, 2018-05-09

• Genome-Wide Analysis Reveals Novel Genes Influencing Temporal Lobe Structure with Relevance to Neurodegeneration in Alzheimer's Disease, 2010-03-01

• Alliance for Aging Research AD Biomarkers Work Group: Structural MRI, 2013-05-06

• Seemingly Unrelated Regression empowers detection of network failure in dementia, 2014-08-27

• The association of mid- to late-life systemic inflammation with white matter structure in older adults: The ARIC Study, 2018-04-04

• Multimodality Imaging Characteristics of Dementia with Lewy Bodies, 2011-10-21

• Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers, 2020-10-06